Epidemiology of COM (mucosal type) in nepal,globally

Reading File
Finding Sources
Searching the Web

epidemiology chronic suppurative otitis media Nepal prevalence

Searching the Web

global epidemiology chronic otitis media prevalence WHO burden

Searching PubMed

"chronic suppurative otitis media" AND epidemiology

Quick answer

Epidemiology of Chronic Otitis Media (Mucosal Type / CSOM) - Nepal and Global

Chronic otitis media, mucosal type (chronic suppurative otitis media, CSOM - a permanent central tympanic membrane perforation with intermittent or persistent mucosal inflammation and otorrhea) is a major global public health problem, particularly in low- and middle-income countries (LMICs).

Global burden

  • CSOM is estimated to affect around 250-330 million people worldwide, with roughly 60% (about 200 million) suffering some degree of hearing impairment as a result.
  • WHO classifies CSOM prevalence bands: <1% = low, 1-4% = high, >4% = very high burden. Populations with the highest rates (often >4%) include Indigenous Australians, Alaskan and Canadian Inuit, Greenlandic Inuit, and some Pacific Island and Sub-Saharan African populations.
  • By WHO region, the South-East Asia and Western Pacific regions contribute roughly 85-90% of the global CSOM burden, with India and China accounting for much of this - India due to high prevalence rate, China due to sheer population size.
  • A 2025 systematic review (Onifade et al., J Epidemiol Glob Health) pooling studies from 18-19 countries (2005-2023) found CSOM prevalence data most commonly from India, Nepal, South Korea, and Bangladesh, and suggested the South-East Asia region may have even greater prevalence than Africa or the Western Pacific.
  • Global Burden of Disease 2021 data show otitis media cases (all types) rose from about 322 million (1992) to 391 million (2021) globally, with a stable/rising incidence but a declining age-standardized prevalence and DALY rate overall - though low and low-middle SDI (socioeconomic development index) regions continue to bear a disproportionate burden.
  • Children under 5 account for a substantial share of cases (roughly 22% of global CSOM incidence), and CSOM disproportionately affects socioeconomically disadvantaged populations, with risk factors including malnutrition, overcrowding, poor hygiene/water access, upper respiratory infections, and limited healthcare access.
  • CSOM can progress to serious complications (mastoiditis, intracranial abscess, meningitis) in a minority of cases, and is linked to worse quality of life, and in some populations, higher rates of depression and anxiety.

Nepal-specific data

Nepal is one of the more heavily studied LMIC settings for CSOM and is generally classified in the high to very high prevalence band:
  • A study from urban private school children in Nepal (Adhikari et al., 2009, Braz J Otorhinolaryngol) found significant CSOM burden among schoolchildren.
  • A more recent Nepali study (eastern Nepal, general population/community screening) reported a CSOM prevalence of 8.2%, with the majority of cases occurring in the 11-15 year age group (51.9%) - indicating school-age children are disproportionately affected.
  • A separate study among Tibetan populations in Nepal also documented high CSOM rates, consistent with the broader pattern of elevated CSOM burden in Indigenous/high-altitude and disadvantaged populations.
  • Nepali patients with CSOM have been shown to report lower quality of life compared with healthy controls, and quality of life improves after corrective (tympanoplasty/mastoid) surgery.
  • Overall, Nepal's rates (roughly 5-8%+ in various community and school-based surveys) place it well above the WHO "high burden" threshold of 4%, reflecting the country's socioeconomic risk factor profile - poor access to ENT care in rural/hill areas, crowding, malnutrition, and high rates of untreated acute otitis media progressing to chronic disease.

Key takeaway

CSOM (mucosal type) is a disease of health inequity: its burden falls overwhelmingly on LMICs and disadvantaged populations, with Nepal contributing well-documented data showing prevalence rates (~5-8%) that place it firmly in the WHO "high/very high burden" category, mirroring the broader South Asian and South-East Asian pattern that accounts for the majority of the global CSOM burden.
Sources synthesized from previously gathered searches: Onifade et al. 2025 (PMC11968643, systematic review), WHO CSOM burden report, GBD 2021 otitis media analysis (Frontiers in Public Health 2024), and Nepal-specific prevalence studies (Adhikari et al. 2009; eastern Nepal community survey).

I need to write in case study so provide me important one only. In short

Epidemiology of COM (Mucosal Type) - Key Points for Case Study

Global:
  • Affects ~250-330 million people worldwide; ~60% (~200 million) have associated hearing impairment.
  • WHO burden classification: <1% low, 1-4% high, >4% very high prevalence.
  • South-East Asia and Western Pacific regions account for ~85-90% of global CSOM burden (India, China contribute most).
  • Disproportionately affects LMICs and disadvantaged/Indigenous populations (highest rates in Aboriginal Australians, Inuit populations, some African and Pacific groups).
  • Children under 5 make up ~22% of global incidence.
Nepal:
  • Falls in the WHO "high/very high burden" category.
  • Community-based study (eastern Nepal): prevalence 8.2%, majority in the 11-15 year age group (51.9%).
  • School-based Nepal study also confirmed significant CSOM burden among children.
  • Risk factors: poor access to ENT care (especially hill/rural areas), overcrowding, malnutrition, untreated acute otitis media.
  • Associated with reduced quality of life, improving after tympanoplasty/mastoid surgery.
Bottom line for case study: CSOM is a disease of health inequity - globally common in LMICs, with Nepal showing prevalence (~8%) well above the WHO "high burden" threshold (4%), predominantly affecting school-age children.

More short. Only provide me needed one

Epidemiology of COM (Mucosal Type):
  • Global: ~250-330 million affected; ~60% have hearing impairment. High burden in South-East Asia/Western Pacific (India, China).
  • Nepal: Prevalence ~8.2%, mostly in 11-15 year age group. Classified as "high burden" (>4%, WHO).
This is a shared conversation. Sign in to Orris to start your own chat.